Work

Neuropsychiatric manifestations of prostate cancer and its treatment: Biological mechanisms and psycho-oncology perspectives

Year: 2026
Type: article
Abstract: Prostate cancer (PCa) is the most frequently diagnosed malignancy in men and a leading cause of cancer-related mortality worldwide. Beyond its oncological burden, PCa is increasingly recognized as a condition with profound psychiatric and neurocognitive implications. Depression, anxiety, sleep disturbance and cognitive decline are highly prevalent among patients, particularly those undergoing androgen deprivation therapy or chemotherapy. The most consistent clinical evidence suggests associations between androgen deprivation therapy and mood-related morbidity, whereas findings for cognition and proposed mechanisms such as inflammation, oxidative stress, hypothalamic-pituitary-adrenal axis dysregulation and altered neural signaling remain heterogeneous and are not uniformly supported by PCa-specific prospective studies. Addressing these dimensions requires a holistic, multidisciplinary model of care in which mental health screening and psychiatric support are integrated into oncology practice. PCa thus serves as a paradigm for understanding the bidirectional relationship between chronic disease, treatment-induced biological stress and psychiatric health. This narrative review links evidence on treatment-related neuropsychiatric outcomes, proposed biological mechanisms, neuroimaging findings, societal aspects of neuropsychiatric morbidity in PCa, while also highlighting important areas for integrated care and future research. Sources such as PubMed/MEDLINE, Scopus, Web of Science, PsycINFO, Google Scholar and reference-list screening were used to identify English-language peer-reviewed literature published from January 2000 to November 2025.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7220975322
FWCI:
Cites: 163
Cited by:
Related to: 10